Skip to Content
Discovering the causes of cancer and the means of prevention

2014 DCEG Fellows Awards for Research Excellence

The DCEG Fellows Awards for Research Excellence (D-FARE) program provides funding for travel to scientific meetings or conferences to fellows who have made exceptional contributions to research projects. These contributions may include formulating research ideas, developing study designs, conducting fieldwork and analysis, or interpreting results. Each of the recognized fellows also must have played a major role in drafting a manuscript. Special consideration is given to projects in which fellows demonstrate growth beyond the discipline of their previous training. 

The D-FARE program was established because scientific meetings are integral to the fellowship experience. The awards enable a greater number of fellows to participate in meetings, where they present their work, hear about new scientific developments, and establish vital connections with other scientists.

This year, seven D-FARE winners were chosen by members of an ad hoc DCEG committee. Winners received a $1,500 travel award to present their research at a scientific meeting.

The 2014 D-FARE recipients and the titles of their abstracts are:

Hannah Arem, M.H.S., Ph.D.
“Leisure time physical activity and mortality: Is more better?”

Clara Bodelon, Ph.D., M.S.
“Transvaginal ultrasound (TVU) scans and detection of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) trial”

Ashley S. Felix, Ph.D., M.P.H.
“Inverse associations between tubal ligation and endometrial cancer stage in the Gynecologic Oncology Group 210 Trial”

Jinping Jia, Ph.D.
“Functional characterization of the pancreatic cancer TERT-CLPTM1L risk locus on chr5p15.33”

Hilary Robbins, M.S.P.H.
“Excess burden of cancer among HIV-infected persons in the United States”

Meredith Shiels, Ph.D.
“Cigarette smoking and systemic immune and inflammation markers”

Britton Trabert, Ph.D., M.S., M.S.P.H.
“Serologic markers of Chlamydia trachomatis infection and ovarian cancer risk”